83
Views
5
CrossRef citations to date
0
Altmetric
Original Research

SP1-Regulated Non-Coding RNA SNHG22 Promotes Ovarian Cancer Growth and Glycolysis

, , , & ORCID Icon
Pages 7299-7309 | Published online: 21 Sep 2021

References

  • WalkerJL, PowellCB, ChenL, et al. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer. 2015;121(13):2108–2120.25820366
  • WebbPM, GreenAC, JordanSJ. Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future. Cancer CausesControl. 2017;28(5):365.
  • CrawfordED, WellsJA. Caspase substrates and cellular remodeling. Annu Rev Biochem. 2011;80:1055–1087.21456965
  • JaysonGC, KohnEC, KitchenerHC, et al. Ovarian cancer. Lancet. 2014;384(9951):1376–1388.24767708
  • BhosaleP, PeungjesadaS, WeiW, et al. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Int J Gynecol Cancer. 2010;20:6.
  • ZhangPF, WuJ, LuoJH, et al. SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma. Aging. 2019;11(19):8204.31581131
  • RonchettiD, ManzoniM, AgnelliL, et al. lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome. Blood Cancer J. 2016;6(9):e468–e468.27611921
  • KoduruSV, LeberfingerAN, KawasawaYI, et al. Non-coding RNAs in various stages of liver disease leading to hepatocellular carcinoma: differential expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs. Sci Rep. 2018;8(1):1–48.29311619
  • FangX, ZhangJ, LiC, et al. Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3. Cancer Cell Int. 2020;20(1):1–12.31908598
  • GatenbyRA, GilliesRJ. Why do cancers have high aerobic glycolysis?Nat Rev Cancer. 2004;4(11):891–899.15516961
  • OuJ, MiaoH, MaY, et al. Loss of abhd5 promotes colorectal tumor development and progression by inducing aerobic glycolysis and epithelial-mesenchymal transition. Cell Rep. 2014;9(5):1798–1811.25482557
  • DohertyJR, ClevelandJL. Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 2013;123(9):3685–3692.23999443
  • WarburgO. On the origin of cancer cells. Science. 1956;123(3191):309–314.13298683
  • Schwartz L, Seyfried T, Alfarouk K O, et al. Out of Warburg effect: An effective cancer treatment targeting the tumor specific metabolism and dysregulated pH. Seminars in cancer biology. Academic Press. 2017;43:134–138.
  • MaroonJ, BostJ, AmosA, et al. Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme. J Child Neurol. 2013;28(8):1002–1008.23670248
  • TianY, MaR, SunY, et al. SP1-activated long noncoding RNA lncRNA GCMA functions as a competing endogenous RNA to promote tumor metastasis by sponging miR-124 and miR-34a in gastric cancer. Oncogene. 2020;39(25):4854–4868.32439864
  • HeJ, LiD, ZhouJ, et al. SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression. Biochem Biophys Res Commun. 2020;526(3):670–677.32248969
  • XuY, YaoY, JiangX, et al. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. J Exp Clin Cancer Res. 2018;37(1):1–13.29301578